LYM08-134

Phase II Study of Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial LYM08-134 being conducted in.
No data was found